Details for 2008729939
Up to date per 01.04.2026
Actions
Details for 2008729939
Granted/Registered
European Patent
02.12.2009 A
28.03.2018 B1
16.02.2007
US
890236 P
02.03.2007
US
892552 P
27.03.2007
US
908205 P
12.07.2007
US
949347 P
27.07.2007
US
952289 P
31.08.2007
US
969192 P
03.10.2007
US
977216 P
A01N 33/16 20060101AFI20090831BHEP
Owner
Novartis Pharma AGLichtstrasse 354056 BaselCH
Representative
Representative
Schwarz & Partner Patentanwälte GmbHWipplingerstraße 301010 WienAT
Inventor
ERICKSON-MILLER, Connie, Lynn1250 South Collegeville Road Collegeville, PA 19426US
Information about Fees